Advertisement
Advertisement
U.S. Markets close in 2 hrs 24 mins
Advertisement
Advertisement
Advertisement
Advertisement

Apellis Pharmaceuticals, Inc. (APLS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
38.30-0.11 (-0.29%)
As of 01:35PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close38.41
Open38.46
Bid38.35 x 800
Ask38.56 x 800
Day's Range38.21 - 40.19
52 Week Range27.50 - 73.00
Volume225,541
Avg. Volume1,059,514
Market Cap3.729B
Beta (5Y Monthly)1.56
PE Ratio (TTM)N/A
EPS (TTM)-6.47
Earnings DateFeb 23, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est69.82
  • GlobeNewswire

    Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    WALTHAM, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company approved the grant of equity awards to one new employee with a grant date of January 3, 2022, as equity inducement awards outside of the company's 2017 Stock Incentive Plan (but under the terms of the 0 Inducement Stock Incentive Plan) and material to the employee’s acceptance of employment with the company.

  • Zacks

    Apellis (APLS) Up More Than 40% in Past 3 Months: Here's Why

    Approval of Apellis' (APLS) Empaveli for treating paroxysmal nocturnal hemoglobinuria lends a significant boost to the company's growth prospects. The drug's label expansion studies also hold promise.

  • GlobeNewswire

    Apellis Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference

    WALTHAM, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 8:15 a.m. ET. The presentation and question and answer session will be available via a live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website.

Advertisement
Advertisement